MAPT and early-onset autosomal dominant Alzheimer disease: Ten-month-old triple-transgenic mice (3xTg) for Alzheimer’s disease (AD), possessing mutant genes Psenl (M146V), APPSwe, and Tau (P301L), were used [5].